Condition
Cerebellum
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownAdvantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD)NCT06669182 · 2025-01-07
RECRUITINGEffects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease SpectrumNCT06756828 · 2025-01-15
NOT_YET_RECRUITINGCerebellar Transcranial Direct Current Stimulation in Parkinson's DiseaseNCT04046055 · 2019-12-01
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED1
NOT_YET_RECRUITING1
RECRUITING1
Phase mix
NA3
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.